Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches

Treatment of patients with heart failure with reduced ejection fraction (HFrEF) with currently available therapies reduces morbidity and mortality. However, implementation of these therapies is a problem with only few patients achieving guideline-recommended maximal doses of therapy. In an effort to...

Descripción completa

Detalles Bibliográficos
Autores principales: Stienen, Susan, Bhatt, Ankeet, Ferreira, João Pedro, Vaduganathan, Muthiah, Januzzi, James, Adams, Kirkwood, Tardif, Jean-Claude, Rossignol, Patrick, Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769782/
https://www.ncbi.nlm.nih.gov/pubmed/32783110
http://dx.doi.org/10.1007/s10741-020-10004-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769782/
https://www.ncbi.nlm.nih.gov/pubmed/32783110
http://dx.doi.org/10.1007/s10741-020-10004-6

Ejemplares similares